Glycomic Analysis of Human Respiratory Tract Tissues and Correlation with Influenza Virus Infection

English version České info

The first step in influenza infection of the human respiratory tract is binding of the virus to sialic (Sia) acid terminated receptors. The binding of different strains of virus for the receptor is determined by the α linkage of the sialic acid to galactose and the adjacent glycan structure. In this study the N- and O-glycan composition of the human lung, bronchus and nasopharynx was characterized by mass spectrometry. Analysis showed that there was a wide spectrum of both Sia α2-3 and α2-6 glycans in the lung and bronchus. This glycan structural data was then utilized in combination with binding data from 4 of the published glycan arrays to assess whether these current glycan arrays were able to predict replication of human, avian and swine viruses in human ex vivo respiratory tract tissues. The most comprehensive array from the Consortium for Functional Glycomics contained the greatest diversity of sialylated glycans, but was not predictive of productive replication in the bronchus and lung. Our findings indicate that more comprehensive but focused arrays need to be developed to investigate influenza virus binding in an assessment of newly emerging influenza viruses.

Vyšlo v časopise: Glycomic Analysis of Human Respiratory Tract Tissues and Correlation with Influenza Virus Infection. PLoS Pathog 9(3): e32767. doi:10.1371/journal.ppat.1003223
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003223

Souhrn

Zdroje

1. NichollsJM, ChanRW, RussellRJ, AirGM, PeirisJS (2008) Evolving complexities of influenza virus and its receptors. Trends Microbiol 16: 149–157.

2. ItoT, CouceiroJN, KelmS, BaumLG, KraussS, et al. (1998) Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 72: 7367–7373.

3. ShinyaK, EbinaM, YamadaS, OnoM, KasaiN, et al. (2006) Avian flu: influenza virus receptors in the human airway. Nature 440: 435–436.

4. BlixtO, HeadS, MondalaT, ScanlanC, HuflejtME, et al. (2004) Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci U S A 101: 17033–17038.

5. StevensJ, BlixtO, TumpeyTM, TaubenbergerJK, PaulsonJC, et al. (2006) Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312: 404–410.

6. StevensJ, BlixtO, ChenLM, DonisRO, PaulsonJC, et al. (2008) Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity. J Mol Biol 381: 1382–1394.

7. ChildsRA, PalmaAS, WhartonS, MatrosovichT, LiuY, et al. (2009) Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat Biotechnol 27: 797–799.

8. YenHL, LiangCH, WuCY, ForrestHL, FergusonA, et al. (2011) Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of the pandemic H1N1 influenza virus in ferrets. Proc Natl Acad Sci U S A 108: 14264–14269.

9. ChanMC, ChanRW, YuWC, HoCC, YuenKM, et al. (2010) Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am J Pathol 176: 1828–1840.

10. NichollsJM, ChanMC, ChanWY, WongHK, CheungCY, et al. (2007) Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med 13: 147–149.

11. ChanRW, ChanMC, WongAC, KaramanskaR, DellA, et al. (2009) DAS181 inhibits H5N1 influenza virus infection of human lung tissues. Antimicrob Agents Chemother 53: 3935–3941.

12. KumariK, GulatiS, SmithDF, GulatiU, CummingsRD, et al. (2007) Receptor binding specificity of recent human H3N2 influenza viruses. Virol J 4: 42.

13. Triana-BaltzerGB, GubarevaLV, NichollsJM, PearceMB, MishinVP, et al. (2009) Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein. PLoS One 4: e7788 doi:10.1371/journal.pone.0007788.

14. BatemanAC, KaramanskaR, BuschMG, DellA, OlsenCW, et al. (2010) Glycan analysis and influenza A virus infection of primary swine respiratory epithelial cells: the importance of NeuAc{alpha}2–6 glycans. J Biol Chem 285: 34016–34026.

15. ChandrasekaranA, SrinivasanA, RamanR, ViswanathanK, RaguramS, et al. (2008) Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat Biotechnol 26: 107–113.

16. NycholatCM, McBrideR, EkiertDC, XuR, RangarajanJ, et al. (2012) Recognition of sialylated poly-N-acetyllactosamine chains on N- and O-linked glycans by human and avian influenza A virus hemagglutinins. Angew Chem Int Ed Engl 51: 4860–4863.

17. XiaB, SachdevGP, CummingsRD (2007) Pseudomonas aeruginosa mucoid strain 8830 binds glycans containing the sialyl-Lewis x epitope. Glycoconj J 24: 87–95.

18. LehmannF, TiralongoE, TiralongoJ (2006) Sialic acid-specific lectins: occurrence, specificity and function. Cell Mol Life Sci 63: 1331–1354.

19. MorelleW, Sutton-SmithM, MorrisHR, DavrilM, RousselP, et al. (2001) FAB-MS characterization of sialyl Lewis x determinants on polylactosamine chains of human airway mucins secreted by patients suffering from cystic fibrosis or chronic bronchitis. Glycoconj J 18: 699–708.

20. HolmenJM, KarlssonNG, AbdullahLH, RandellSH, SheehanJK, et al. (2004) Mucins and their O-Glycans from human bronchial epithelial cell cultures. Am J Physiol Lung Cell Mol Physiol 287: L824–834.

21. XiaB, RoyallJA, DameraG, SachdevGP, CummingsRD (2005) Altered O-glycosylation and sulfation of airway mucins associated with cystic fibrosis. Glycobiology 15: 747–775.

22. SatomaaT, HeiskanenA, LeonardssonI, AngstromJ, OlonenA, et al. (2009) Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens. Cancer Res 69: 5811–5819.

23. HosslerP, KhattakSF, LiZJ (2009) Optimal and consistent protein glycosylation in mammalian cell culture. Glycobiology 19: 936–949.

24. NichollsJM, BourneAJ, ChenH, GuanY, PeirisJS (2007) Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses. Respir Res 8: 73.

25. FiebigL, SoykaJ, BudaS, BuchholzU, DehnertM, et al. Avian influenza A(H5N1) in humans: new insights from a line list of World Health Organization confirmed cases, September 2006 to August 2010. Euro Surveill 16

26. RademacherC, PaulsonJC (2012) Glycan fingerprints: calculating diversity in glycan libraries. ACS Chem Biol 7: 829–834.

27. de WitE, MunsterVJ, van RielD, BeyerWE, RimmelzwaanGF, et al. (2010) Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host. J Virol 84: 1597–1606.

28. BelserJA, BlixtO, ChenLM, PappasC, MainesTR, et al. (2008) Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility. Proc Natl Acad Sci U S A 105: 7558–7563.

29. MunsterVJ, de WitE, van RielD, BeyerWE, RimmelzwaanGF, et al. (2007) The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses. J Infect Dis 196: 258–265.

30. van EijkM, WhiteMR, BatenburgJJ, VaandragerAB, van GoldeLM, et al. (2004) Interactions of influenza A virus with sialic acids present on porcine surfactant protein D. Am J Respir Cell Mol Biol 30: 871–879.

31. ShiehWJ, BlauDM, DenisonAM, Deleon-CarnesM, AdemP, et al. (2010) 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol 177: 166–175.

32. XuR, McBrideR, NycholatCM, PaulsonJC, WilsonIA (2012) Structural characterization of the hemagglutinin receptor specificity from the 2009 H1N1 influenza pandemic. J Virol 86: 982–990.

33. ChenLM, RivaillerP, HossainJ, CarneyP, BalishA, et al. (2011) Receptor specificity of subtype H1 influenza A viruses isolated from swine and humans in the United States. Virology 412: 401–410.

34. ImaiM, WatanabeT, HattaM, DasSC, OzawaM, et al. (2012) Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486: 420–428.

35. ChanRW, KangSS, YenHL, LiAC, TangLL, et al. (2011) Tissue tropism of swine influenza viruses and reassortants in ex vivo cultures of the human respiratory tract and conjunctiva. J Virol 85: 11581–11587.

36. Jang-LeeJ, NorthSJ, Sutton-SmithM, GoldbergD, PanicoM, et al. (2006) Glycomic profiling of cells and tissues by mass spectrometry: fingerprinting and sequencing methodologies. Methods Enzymol 415: 59–86.

37. GulatiS, SmithDF, AirGM (2009) Deletions of neuraminidase and resistance to oseltamivir may be a consequence of restricted receptor specificity in recent H3N2 influenza viruses. Virol J 6: 22.

38. ChanMC, ChanRW, YuWC, HoCC, YuenKM, et al. (2010) Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. The American journal of pathology 176: 1828–1840.

39. ChanRW, KangSS, YenHL, LiAC, TangLL, et al. (2011) Tissue tropism of swine influenza viruses and reassortants in ex vivo cultures of the human respiratory tract and conjunctiva. Journal of virology 85: 11581–11587.

40. NichollsJM, ChanMC, ChanWY, WongHK, CheungCY, et al. (2007) Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nature medicine 13: 147–149.